Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

Tuberculosis (TB) continues to be a major global health disaster, despite the widespread use of BCG and effective drug therapies. The development of an efficacious new TB vaccine would be an important component of disease control in the future. Many approaches are being utilised to enhance understan...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Sander, C, Mcshane, H
Natura:	Journal article
Lingua:	English
Pubblicazione:	2007

Documenti analoghi

Developing an improved vaccine against tuberculosis.
di: Mcshane, H
Pubblicazione: (2004)

Vaccine strategies against tuberculosis.
di: Mcshane, H
Pubblicazione: (2009)

Vaccine strategies against tuberculosis
di: H McShane
Pubblicazione: (2009-03-01)

Vaccines for tuberculosis
di: McShane, H
Pubblicazione: (2013)

Insights and challenges in tuberculosis vaccine development
di: McShane, H
Pubblicazione: (2019)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
di: Fletcher, H, et al.
Pubblicazione: (2009)

Tuberculosis vaccines in clinical trials.
di: Rowland, R, et al.
Pubblicazione: (2011)

Tuberculosis vaccines: progress and challenges.
di: Checkley, A, et al.
Pubblicazione: (2011)

Tuberculosis vaccines: present and future.
di: Minassian, A, et al.
Pubblicazione: (2008)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
di: McShane, H
Pubblicazione: (2023)

Vaccination against tuberculosis: how can we better BCG?
di: Pitt, J, et al.
Pubblicazione: (2013)

Vaccination against tuberculosis: How can we better BCG?
di: Pitt, J, et al.
Pubblicazione: (2013)

Tuberculosis vaccines: Progress and challenges
di: Checkley, A, et al.
Pubblicazione: (2011)

Tuberculosis vaccine promises sterilizing immunity.
di: Mcshane, H, et al.
Pubblicazione: (2011)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
di: McShane, H
Pubblicazione: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
di: McShane, H
Pubblicazione: (2011)

Tuberculosis vaccines: current status and future prospects.
di: Fletcher, H, et al.
Pubblicazione: (2006)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle.
di: Villarreal-Ramos, B, et al.
Pubblicazione: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
di: Villarreal-Ramos, B, et al.
Pubblicazione: (2014)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
di: Vermaak, S, et al.
Pubblicazione: (2023)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
di: Hopkins, R, et al.
Pubblicazione: (2011)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
di: Villarreal-Ramos, B, et al.
Pubblicazione: (2017)

Clinical testing of tuberculosis vaccine candidates
di: Hatherill, M, et al.
Pubblicazione: (2016)

WHO preferred product characteristics for new vaccines against tuberculosis
di: Schrager, L, et al.
Pubblicazione: (2018)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
di: Vordermeier, H, et al.
Pubblicazione: (2009)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
di: Richard Hopkins, et al.
Pubblicazione: (2011-01-01)

Development of a primate model for tuberculosis vaccine research: IFN-gamma responses induced by BCG vaccination and M-tuberculosis infection in macaques
di: Dowall, S, et al.
Pubblicazione: (2007)

Identification of antigens presented by MHC for vaccines against tuberculosis
di: Bettencourt, P, et al.
Pubblicazione: (2020)

Mini review on Potency Evaluation of Rabies Vaccine preparations
di: Walaa Rashed, et al.
Pubblicazione: (2021-12-01)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
di: de Cassan, S, et al.
Pubblicazione: (2010)

Why don’t we have an effective tuberculosis vaccine yet?
di: Davenne, T, et al.
Pubblicazione: (2016)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
di: Griffiths, K, et al.
Pubblicazione: (2013)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
di: Stylianou, E, et al.
Pubblicazione: (2019)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
di: Mcshane, H, et al.
Pubblicazione: (2016)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
di: Vordermeier, H, et al.
Pubblicazione: (2011)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
di: Mcshane, H, et al.
Pubblicazione: (2005)

Identification of antigens presented by MHC for vaccines against tuberculosis
di: Bettencourt, P, et al.
Pubblicazione: (2020)

ON VACCINATION OF ADOLESCENTS AGAINST TUBERCULOSIS
di: L. A. Zazimko, et al.
Pubblicazione: (2014-01-01)

Reactive arthritis after vaccination against SARS-CoV-2: A case series and a mini-review
di: Wiktoria Wojturska, et al.
Pubblicazione: (2023-01-01)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG immunized adults vaccinated with a new tuberculosis vaccine, MVA85A (Clinical and Vaccine Immunology (2010) 17, 7, (1066-1073))
di: De Cassan, S, et al.
Pubblicazione: (2011)